Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
UTMD's Cash to Debt is ranked higher than
96% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. UTMD: No Debt )
Ranked among companies with meaningful Cash to Debt only.
UTMD' s 10-Year Cash to Debt Range
Min: 0.01  Med: 3.47 Max: No Debt
Current: No Debt
Equity to Asset 0.85
UTMD's Equity to Asset is ranked higher than
88% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. UTMD: 0.85 )
Ranked among companies with meaningful Equity to Asset only.
UTMD' s 10-Year Equity to Asset Range
Min: 0.42  Med: 0.81 Max: 0.92
Current: 0.85
0.42
0.92
Interest Coverage 56.06
UTMD's Interest Coverage is ranked higher than
52% of the 105 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.02 vs. UTMD: 56.06 )
Ranked among companies with meaningful Interest Coverage only.
UTMD' s 10-Year Interest Coverage Range
Min: 13.79  Med: 52.47 Max: 9999.99
Current: 56.06
13.79
9999.99
F-Score: 6
Z-Score: 13.30
M-Score: -2.60
WACC vs ROIC
8.61%
22.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 38.95
UTMD's Operating margin (%) is ranked higher than
97% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.42 vs. UTMD: 38.95 )
Ranked among companies with meaningful Operating margin (%) only.
UTMD' s 10-Year Operating margin (%) Range
Min: 22.54  Med: 35.96 Max: 57.84
Current: 38.95
22.54
57.84
Net-margin (%) 27.16
UTMD's Net-margin (%) is ranked higher than
96% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.58 vs. UTMD: 27.16 )
Ranked among companies with meaningful Net-margin (%) only.
UTMD' s 10-Year Net-margin (%) Range
Min: 17.69  Med: 24.31 Max: 76.5
Current: 27.16
17.69
76.5
ROE (%) 17.66
UTMD's ROE (%) is ranked higher than
83% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.05 vs. UTMD: 17.66 )
Ranked among companies with meaningful ROE (%) only.
UTMD' s 10-Year ROE (%) Range
Min: 15.87  Med: 21.87 Max: 79.46
Current: 17.66
15.87
79.46
ROA (%) 13.95
UTMD's ROA (%) is ranked higher than
89% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. UTMD: 13.95 )
Ranked among companies with meaningful ROA (%) only.
UTMD' s 10-Year ROA (%) Range
Min: 12.61  Med: 17.53 Max: 56.82
Current: 13.95
12.61
56.82
ROC (Joel Greenblatt) (%) 113.09
UTMD's ROC (Joel Greenblatt) (%) is ranked higher than
97% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.82 vs. UTMD: 113.09 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UTMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 25.57  Med: 78.94 Max: 114.57
Current: 113.09
25.57
114.57
Revenue Growth (3Y)(%) 1.70
UTMD's Revenue Growth (3Y)(%) is ranked lower than
61% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. UTMD: 1.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UTMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -6.6  Med: 8.00 Max: 16.5
Current: 1.7
-6.6
16.5
EBITDA Growth (3Y)(%) 8.50
UTMD's EBITDA Growth (3Y)(%) is ranked higher than
55% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. UTMD: 8.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UTMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -6.4  Med: 9.60 Max: 30.9
Current: 8.5
-6.4
30.9
EPS Growth (3Y)(%) 14.00
UTMD's EPS Growth (3Y)(%) is ranked higher than
62% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. UTMD: 14.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UTMD' s 10-Year EPS Growth (3Y)(%) Range
Min: -10.4  Med: 10.40 Max: 24.6
Current: 14
-10.4
24.6
» UTMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

UTMD Guru Trades in Q2 2014

Jim Simons 87,300 sh (+8.72%)
Chuck Royce 44,100 sh (+1.38%)
» More
Q3 2014

UTMD Guru Trades in Q3 2014

Jim Simons 87,700 sh (+0.46%)
Chuck Royce 44,300 sh (+0.45%)
» More
Q4 2014

UTMD Guru Trades in Q4 2014

Jim Simons 88,700 sh (+1.14%)
Chuck Royce 40,100 sh (-9.48%)
» More
Q1 2015

UTMD Guru Trades in Q1 2015

Chuck Royce 41,000 sh (+2.24%)
Jim Simons 90,000 sh (+1.47%)
» More
» Details

Insider Trades

Latest Guru Trades with UTMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.83
UTMD's P/E(ttm) is ranked higher than
78% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.20 vs. UTMD: 17.83 )
Ranked among companies with meaningful P/E(ttm) only.
UTMD' s 10-Year P/E(ttm) Range
Min: 3.59  Med: 15.79 Max: 21.38
Current: 17.83
3.59
21.38
Forward P/E 13.25
UTMD's Forward P/E is ranked higher than
84% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.03 vs. UTMD: 13.25 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 17.90
UTMD's PE(NRI) is ranked higher than
76% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.60 vs. UTMD: 17.90 )
Ranked among companies with meaningful PE(NRI) only.
UTMD' s 10-Year PE(NRI) Range
Min: 4.17  Med: 15.82 Max: 21.35
Current: 17.9
4.17
21.35
P/B 3.14
UTMD's P/B is ranked lower than
53% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.85 vs. UTMD: 3.14 )
Ranked among companies with meaningful P/B only.
UTMD' s 10-Year P/B Range
Min: 1.97  Med: 2.83 Max: 4.13
Current: 3.14
1.97
4.13
P/S 4.87
UTMD's P/S is ranked lower than
66% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.84 vs. UTMD: 4.87 )
Ranked among companies with meaningful P/S only.
UTMD' s 10-Year P/S Range
Min: 2.56  Med: 4.06 Max: 5.67
Current: 4.87
2.56
5.67
PFCF 13.31
UTMD's PFCF is ranked higher than
90% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.29 vs. UTMD: 13.31 )
Ranked among companies with meaningful PFCF only.
UTMD' s 10-Year PFCF Range
Min: 3.06  Med: 15.20 Max: 25.57
Current: 13.31
3.06
25.57
POCF 12.86
UTMD's POCF is ranked higher than
73% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.15 vs. UTMD: 12.86 )
Ranked among companies with meaningful POCF only.
UTMD' s 10-Year POCF Range
Min: 3  Med: 13.99 Max: 23.67
Current: 12.86
3
23.67
EV-to-EBIT 11.45
UTMD's EV-to-EBIT is ranked higher than
80% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.59 vs. UTMD: 11.45 )
Ranked among companies with meaningful EV-to-EBIT only.
UTMD' s 10-Year EV-to-EBIT Range
Min: 6  Med: 9.80 Max: 14.6
Current: 11.45
6
14.6
PEG 1.16
UTMD's PEG is ranked higher than
85% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. UTMD: 1.16 )
Ranked among companies with meaningful PEG only.
UTMD' s 10-Year PEG Range
Min: 0.44  Med: 1.93 Max: 11.73
Current: 1.16
0.44
11.73
Shiller P/E 21.30
UTMD's Shiller P/E is ranked higher than
76% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.99 vs. UTMD: 21.30 )
Ranked among companies with meaningful Shiller P/E only.
UTMD' s 10-Year Shiller P/E Range
Min: 8.31  Med: 14.02 Max: 26.58
Current: 21.3
8.31
26.58
Current Ratio 5.00
UTMD's Current Ratio is ranked higher than
83% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. UTMD: 5.00 )
Ranked among companies with meaningful Current Ratio only.
UTMD' s 10-Year Current Ratio Range
Min: 1.6  Med: 4.26 Max: 14.9
Current: 5
1.6
14.9
Quick Ratio 4.09
UTMD's Quick Ratio is ranked higher than
81% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. UTMD: 4.09 )
Ranked among companies with meaningful Quick Ratio only.
UTMD' s 10-Year Quick Ratio Range
Min: 0.93  Med: 2.71 Max: 12.96
Current: 4.09
0.93
12.96
Days Inventory 110.50
UTMD's Days Inventory is ranked higher than
64% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 129.36 vs. UTMD: 110.50 )
Ranked among companies with meaningful Days Inventory only.
UTMD' s 10-Year Days Inventory Range
Min: 81.67  Med: 99.65 Max: 189.66
Current: 110.5
81.67
189.66
Days Sales Outstanding 43.90
UTMD's Days Sales Outstanding is ranked higher than
84% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.83 vs. UTMD: 43.90 )
Ranked among companies with meaningful Days Sales Outstanding only.
UTMD' s 10-Year Days Sales Outstanding Range
Min: 32.55  Med: 45.85 Max: 70.68
Current: 43.9
32.55
70.68

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.89
UTMD's Dividend Yield is ranked higher than
67% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. UTMD: 1.89 )
Ranked among companies with meaningful Dividend Yield only.
UTMD' s 10-Year Dividend Yield Range
Min: 1.33  Med: 2.52 Max: 4.23
Current: 1.89
1.33
4.23
Dividend Payout 0.34
UTMD's Dividend Payout is ranked higher than
56% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. UTMD: 0.34 )
Ranked among companies with meaningful Dividend Payout only.
UTMD' s 10-Year Dividend Payout Range
Min: 0.27  Med: 0.40 Max: 0.64
Current: 0.34
0.27
0.64
Dividend growth (3y) 2.10
UTMD's Dividend growth (3y) is ranked lower than
72% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.10 vs. UTMD: 2.10 )
Ranked among companies with meaningful Dividend growth (3y) only.
UTMD' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 25.3
Current: 2.1
0
25.3
Yield on cost (5-Year) 2.84
UTMD's Yield on cost (5-Year) is ranked higher than
73% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.65 vs. UTMD: 2.84 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
UTMD' s 10-Year Yield on cost (5-Year) Range
Min: 2  Med: 3.79 Max: 6.36
Current: 2.84
2
6.36
Share Buyback Rate -1.20
UTMD's Share Buyback Rate is ranked higher than
60% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. UTMD: -1.20 )
Ranked among companies with meaningful Share Buyback Rate only.
UTMD' s 10-Year Share Buyback Rate Range
Min: 14.4  Med: 5.10 Max: -1.2
Current: -1.2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 43.76
UTMD's Price/Net Cash is ranked lower than
72% of the 39 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.22 vs. UTMD: 43.76 )
Ranked among companies with meaningful Price/Net Cash only.
UTMD' s 10-Year Price/Net Cash Range
Min: 5.01  Med: 8.07 Max: 812.67
Current: 43.76
5.01
812.67
Price/Net Current Asset Value 13.22
UTMD's Price/Net Current Asset Value is ranked lower than
62% of the 100 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.96 vs. UTMD: 13.22 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
UTMD' s 10-Year Price/Net Current Asset Value Range
Min: 3.44  Med: 8.65 Max: 955
Current: 13.22
3.44
955
Price/Tangible Book 8.78
UTMD's Price/Tangible Book is ranked lower than
77% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. UTMD: 8.78 )
Ranked among companies with meaningful Price/Tangible Book only.
UTMD' s 10-Year Price/Tangible Book Range
Min: 2.49  Med: 4.41 Max: 133.52
Current: 8.78
2.49
133.52
Price/Projected FCF 1.00
UTMD's Price/Projected FCF is ranked higher than
78% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. UTMD: 1.00 )
Ranked among companies with meaningful Price/Projected FCF only.
UTMD' s 10-Year Price/Projected FCF Range
Min: 0.49  Med: 0.82 Max: 1.27
Current: 1
0.49
1.27
Price/Median PS Value 1.20
UTMD's Price/Median PS Value is ranked higher than
55% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.27 vs. UTMD: 1.20 )
Ranked among companies with meaningful Price/Median PS Value only.
UTMD' s 10-Year Price/Median PS Value Range
Min: 0.38  Med: 0.90 Max: 1.37
Current: 1.2
0.38
1.37
Price/Peter Lynch Fair Value 1.13
UTMD's Price/Peter Lynch Fair Value is ranked higher than
85% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.98 vs. UTMD: 1.13 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
UTMD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.44  Med: 1.28 Max: 3.26
Current: 1.13
0.44
3.26
Price/Graham Number 2.64
UTMD's Price/Graham Number is ranked lower than
51% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. UTMD: 2.64 )
Ranked among companies with meaningful Price/Graham Number only.
UTMD' s 10-Year Price/Graham Number Range
Min: 1.08  Med: 1.61 Max: 8.81
Current: 2.64
1.08
8.81
Earnings Yield (Greenblatt) (%) 8.74
UTMD's Earnings Yield (Greenblatt) (%) is ranked higher than
87% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. UTMD: 8.74 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UTMD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.9  Med: 10.20 Max: 16.8
Current: 8.74
6.9
16.8
Forward Rate of Return (Yacktman) (%) 21.48
UTMD's Forward Rate of Return (Yacktman) (%) is ranked higher than
78% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.94 vs. UTMD: 21.48 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
UTMD' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 2.8  Med: 14.85 Max: 23.6
Current: 21.48
2.8
23.6

Analyst Estimate

Dec15
EPS($) 3.95
EPS without NRI($) 3.95

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Utah Medical Products Inc was formed as a Utah corporation in 1978. The Company is in the business of producing medical devices that are predominantly proprietary, disposable and for hospital use. The Company's products include those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians' offices. Products are sold in both domestic U.S. and international markets. The Company with particular interest in healthcare for women and their babies, develops, manufactures, assembles and markets disposable and reusable specialty medical devices designed for health outcomes for patients and their care-providers. It produces medical devices for Blood Pressure Monitoring and Blood Collection, Electrosurgery, Gynecology, Neonatal Critical Care, Perinatology and Urology. The Company's VAD Systems includes CMI patented soft silicone bell-shaped birthing cups and patented hand-held vacuum pumps. AROM-COT is a finger cover with a patented prong design to rupture maternal membranes with less patient pain and anxiety. The DISPOSA-HOOD is an infant respiratory hood that is used in the NICU to administer oxygen to neonates and flush CO2 while maintaining a neutral thermal environment critical to proper physiologic responses. The Company's DELTRAN blood pressure monitoring system has been adapted specifically for use in the Neonatal intensive care unit. The streamlined version eliminates needles used for blood sampling, avoids the loss of scarce neonatal blood volume and provides a closed system that reduces the risk of infection. The LETZ System (loop excision of the transformation zone) is used to excise cervical intraepithelial neoplasia (CIN) and other lower genital tract lesions related to human papilloma virus (HPV) infections. The Company's LETZ System includes patented disposable electrodes, the patented FINESSE electrosurgical generator, and other miscellaneous components. EPITOME is a patented electrosurgical scalpel which delivers precise performance in incision and excision with hemostasis while minimizing thermal side effects. LIBERTY is a device for the conservative treatment and effective control of urinary incontinence in women. LIBERTY is the easiest-to-use, cost effective incontinence treatment available that yields a therapeutic effect, not just a cover-up. LIBERTY consists of a battery operated electrical stimulation unit and an intravaginal electrode probe. In pressure monitoring, a transducer is used to convert physiological (mechanical) pressure into an electrical signal that is displayed on electronic monitoring equipment. It developed, patented and is now distributing its disposable transducer as a stand-alone product, and as a component in sterile blood pressure monitoring kits through direct representatives and other medical companies in the U.S., as well as independent distributors and other medical device companies internationally. The Company's products
» More Articles for UTMD

Headlines

Articles On GuruFocus.com
4 Top-Performing Healthcare Dividend Stocks with Single-Digit P/Es Jul 02 2013 
comment on UTMD May 16 2013 
comment on UTMD Aug 15 2012 
How to Screen for Hidden Champions Mar 23 2012 
10 High Margin Healthcare Dividend Shares Jan 02 2012 
Utah Medical Products, Inc: Stable Operator Rocks The Boat Sep 22 2011 
Utah Medical Products Inc. Reports Operating Results (10-Q) Nov 04 2010 
Utah Medical Products Inc. Reports Operating Results (10-Q) Aug 05 2010 
Utah Medical Products Inc. Dabbles in Stocks May 26 2010 
Utah Medical Products Inc. Reports Operating Results (10-Q) May 10 2010 

More From Other Websites
Utah Medical Products, Inc. Announces Quarterly Dividend Jul 30 2015
Utah Medical Products, Inc. Announces Quarterly Dividend Jul 30 2015
UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition Jul 23 2015
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2015 Jul 23 2015
Utah Medical posts 2Q profit Jul 23 2015
Utah Medical posts 2Q profit Jul 23 2015
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2015 Jul 23 2015
UTAH MEDICAL PRODUCTS INC Financials May 15 2015
10-Q for Utah Medical Products, Inc. May 08 2015
10-K for Utah Medical Products, Inc. May 06 2015
UTAH MEDICAL PRODUCTS INC Files SEC form 10-Q, Quarterly Report May 06 2015
Utah Medical Products, Inc. Announces Quarterly Dividend May 05 2015
Utah Medical Products, Inc. Announces Quarterly Dividend May 05 2015
UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 04 2015
UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition Apr 23 2015
Utah Medical posts 1Q profit Apr 23 2015
Utah Medical posts 1Q profit Apr 23 2015
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2015 Apr 23 2015
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2015 Apr 23 2015
UTAH MEDICAL PRODUCTS INC Files SEC form 10-K, Annual Report Mar 12 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK